The DOI matches its Crossref record; 231 of the 232 references it cites were found in a registry or an index.
Inhibiting NF-κB activation by small molecules as a therapeutic strategy
Open accessAbstract
Because nuclear factor-κB (NF-κB) is a ubiquitously expressed proinflammatory transcription factor that regulates the expression of over 500 genes involved in cellular transformation, survival, proliferation, invasion, angiogenesis, metastasis, and inflammation, the NF-κB signaling pathway has become a potential target for pharmacological intervention. A wide variety of agents can activate NF-κB through canonical and noncanonical pathways. Canonical pathway involves various steps including the phosphorylation, ubiquitination, and degradation of the inhibitor of NF-κB (IκBα), which leads to the nuclear translocation of the p50-p65 subunits of NF-κB followed by p65 phosphorylation, acetylation and methylation, DNA binding, and gene transcription. Thus, agents that can inhibit protein kinases, protein phosphatases, proteasomes, ubiquitination, acetylation, methylation, and DNA binding steps have been identified as NF-κB inhibitors. Because of the critical role of NF-κB in cancer and various chronic diseases, numerous inhibitors of NF-κB have been identified. In this review, however, we describe only small molecules that suppress NF-κB activation, and the mechanism by which they block this pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NF-kappB (NF-KB) has been studied for more than 25 years and is known to be expressed in all cell types, where it is involved in the oxidative stress mechanism by the expression of numerous genes, such as the cytokines, and plays a major role in the pathology of inflammatory disease [104,105].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
D’Acquisto, F., Ialenti, A., Ianaro, A., Vaio, R. D., & Carnuccio, R. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301295 · Cited by 65
RetractedRosato, R. R., Kolla, S. S., Hock, S. K., Almenara, J. A., Patel, A. K., Amin, S., Atadja, P. W., Fisher, P. B., Dent, P., & Grant, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095208 · Cited by 64
RetractedNF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 1×
“In resting cells, NF-κB proteins are kept in the cytoplasm in association with inhibitory IkB proteins including IκBα, IκBβ, and IκBε [15] among which IκBα is the most abundant.”
Activators and Target Genes of Rel/NF-кB Transcription Factors
Loop, T., & Pahl, H. L. (2003) · Springer eBooks · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,179
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,754
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
Flagged first, then by citations
1 of the 232 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 771
Jha, N. K., Arfin, S., Jha, S. K., Kar, R., Dey, A., Gundamaraju, R., Ashraf, G. M., Gupta, P. K., Dhanasekaran, S., Abomughaid, M. M., et al. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.022 · Cited by 54
Grenier, D., Morin, M.-P., Fournier-Larente, J., & Chen, H. (2015) · Journal of Periodontal Research · doi:10.1111/jre.12315 · Cited by 51
Hernández‐Abreu, O., Torres‐Piedra, M., García‐Jiménez, S., Ibarra-Barajas, M., Villalobos‐Molina, R., Montes, S., Rembao, D., & Estrada-Soto, S. E. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.12.029 · Cited by 51
NF-κB as a potential therapeutic target in microbial diseases
Vitiello, M., Galdiero, M., Finamore, E., Galdiero, S., & Galdiero, M. (2012) · Molecular BioSystems · doi:10.1039/c2mb05335g · Cited by 52
Oxidative Stress and Cancer Development: Are Noncoding RNAs the Missing Links?
D’Souza, L. C., Mishra, S., Chakraborty, A., Shekher, A., Sharma, A., & Gupta, S. C. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7987 · Cited by 51
Self-citationDuncan, H. F., Smith, A. J., Fleming, G. J. P., & Cooper, P. R. (2011) · Journal of Dental Research · doi:10.1177/0022034511406919 · Cited by 52
NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances
Wu, X., Sun, L., & Xu, F. (2023) · Pharmaceuticals · doi:10.3390/ph16060783 · Cited by 51
New Ideas for the Prevention and Treatment of Preeclampsia and Their Molecular Inspirations
Sakowicz, A., Bralewska, M., Rybak-Krzyszkowska, M., Grzesiak, M., & Pietrucha, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512100 · Cited by 51
Liu, D., Gong, G.-H., Wei, C.-X., Jin, X.-J., & Quan, Z. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.02.008 · Cited by 49
Hsueh, T.-P., Sheen, J.-M., Pang, J. S., Bi, K.-W., Huang, C., Wu, H., & Huang, S. (2016) · Molecules · doi:10.3390/molecules21020195 · Cited by 50
Preventive effect of Gardenia jasminoides on HCl/ethanol induced gastric injury in mice
Chen, S., Zhao, X., Sun, P., Qian, J., Shi, Y., & Wang, R. (2016) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2016.05.011 · Cited by 49
Guo, X., Zheng, L., Jiang, J., Zhao, Y., Wang, X., Shen, M., Zhu, F., Tian, R., Shi, C., Xu, M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1144 · Cited by 49
Fan, X., Zhu, J., Sun, Y., Luo, L., Yan, J., Yang, X., Yu, J. H., Tang, W., Ma, W., & Liang, H. (2017) · Inflammation · doi:10.1007/s10753-017-0546-0 · Cited by 49
Zhang, C., Chen, B., Jiang, K., Lao, L., Shen, H., & Chen, Z. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12176 · Cited by 49
Marine Low Molecular Weight Natural Products as Potential Cancer Preventive Compounds
Stonik, V. A., & Fedorov, S. N. (2014) · Marine Drugs · doi:10.3390/md12020636 · Cited by 48
Meng, G., Tang, X., Yang, Z., Benesch, M. G. K., Marshall, A., Murray, D. L., Hemmings, D. G., Wuest, F. R., McMullen, T. P. W., & Brindley, D. N. (2017) · The FASEB Journal · doi:10.1096/fj.201700159r · Cited by 48
Edaravone attenuates traumatic brain injury through anti‑inflammatory and anti‑oxidative modulation
Zhang, M., Teng, C., Wu, F., Ge, L., Xiao, J., Zhang, H., & Chen, D. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7632 · Cited by 51
Guzmán, E. A., Maers, K., Roberts, J. C., Wangun, H. V. K., Harmody, D. K., & Wright, A. E. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0185-3 · Cited by 48
Kang, S. G., Lee, G. B., Vinayagam, R., Do, G. S., Oh, S. Y., Yang, S. J., Kwon, J. B., & Singh, M. V. (2022) · Molecules · doi:10.3390/molecules27217432 · Cited by 48
Pintha, K., Yodkeeree, S., & Limtrakul, P. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00719 · Cited by 47
Rhododendrin ameliorates skin inflammation through inhibition of NF-κB, MAPK, and PI3K/Akt signaling
Jeon, Y.-J., Kim, B.-H., Kim, S., Oh, I., Lee, S., Shin, J., & Kim, T. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.05.041 · Cited by 48
Relevance of new drug discovery to reduce NF-κB activation in cardiovascular disease
Madonna, R., & De Caterina, R. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.005 · Cited by 46
Davies, R., Sarkar, I., Hammenfors, D., Bergum, B., Vogelsang, P., Solberg, S. M., Gavasso, S., Brun, J. G., Jonsson, R., & Appel, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00281 · Cited by 45
On the Immunometabolic Role of NF-κB in Adipocytes
Griffin, M. J. (2022) · Immunometabolism · doi:10.20900/immunometab20220003 · Cited by 48
Ruiz-Miyazawa, K. W., Zarpelon, A. C., Pinho-Ribeiro, F. A., Pavão-de-Souza, G. F., Casagrande, R., & Verri, W. A., Jr. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118942 · Cited by 46
Irradiation at 636 nm Positively Affects Diabetic Wounded and Hypoxic Cells in Vitro
Sekhejane, P. R., Houreld, N. N., & Abrahamse, H. (2011) · Photomedicine and Laser Surgery · doi:10.1089/pho.2010.2877 · Cited by 46
Mohan, C. D., Bharathkumar, H., Dukanya, Rangappa, S., Shanmugam, M. K., Chinnathambi, A., Alharbi, S. A., Alahmadi, T. A., Bhattacharjee, A., Lobie, P. E., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01125 · Cited by 46
Ambrosini, G., Do, C., Tycko, B., Realubit, R. B., Karan, C., Musi, E., Carvajal, R. D., Chua, V. Y. L., Aplin, A. E., & Schwartz, G. K. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3177 · Cited by 48
Paish, H. L., Kalson, N. S., Smith, G. R., Pons, A. D. C., Baldock, T., Smith, N., Swist-Szulik, K., Weir, D. J., Bardgett, M., Deehan, D. J., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.11.007 · Cited by 45
Campos, A. C. P., Kikuchi, D. S., Paschoa, A. F. N., Kuroki, M. A., Fonoff, E. T., Hamani, C., Pagano, R. L., & Hernandes, M. S. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00784-3 · Cited by 45
Billot, K., Sœur, J., Chéreau, F., Arrouss, I., Merle‐Béral, H., Huang, M., Mazier, D., Baud, V., & Rebollo, A. (2010) · Blood · doi:10.1182/blood-2010-09-307140 · Cited by 45
Yin, L., Sun, C., Zhang, J., Li, Y., Wang, Y., Bai, L., & Lei, Z. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1639430 · Cited by 45
Oguiza, A., Recio, C., Lázaro, I., Mallavia, B., Blanco, J., Egido, J., & Gómez‐Guerrero, C. (2015) · Diabetologia · doi:10.1007/s00125-015-3596-6 · Cited by 44
Narayanan, D., Nair, S. V., & Menon, D. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.12.012 · Cited by 44
Tonby, K., Wergeland, I., Lieske, N., Kvale, D., Taskén, K., & Dyrhol‐Riise, A. M. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1938-8 · Cited by 43
Li, M., Zhao, J.-Q., & Jia, L. (2019) · Life Science · doi:10.1016/j.lfs.2018.12.014 · Cited by 37
Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease
Nayeri, T., Sarvi, S., Sharif, M., & Daryani, A. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07151 · Cited by 46
Plexin-B1 Activates NF-κB and IL-8 to Promote a Pro-Angiogenic Response in Endothelial Cells
Yang, Y.-H., Zhou, H., Binmadi, N. O., Proia, P., & Basile, J. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025826 · Cited by 43
RetractedWei, N., Zhang, C., He, H., Wang, T., Liu, Z., Liu, G., Sun, Z., Zhou, Z., Bai, C.-H., & Yuan, D. (2014) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12291 · Cited by 43
Lagha, A. B., & Grenier, D. (2016) · Journal of Periodontal Research · doi:10.1111/jre.12411 · Cited by 43
Soria, W., Villagomez, R., Smiljanic, S., Huang, X., Malakpour, A., Kempengren, S., Rodrigo, G., Almanza, G. R., Sterner, O., & Oredsson, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184304 · Cited by 43
Brezáni, V., Šmejkal, K., Jakubczyk, K., Veselý, O., Landa, P., Václavík, J., Bobáľ, P., Pížová, H., Temml, V., Steinacher, T., et al. (2019) · Food Chemistry · doi:10.1016/j.foodchem.2019.01.128 · Cited by 43
Wu, X., Qi, J., Bradner, J. E., Xiao, G., & Chen, L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.485029 · Cited by 45
Astarcı, E., Sade, A., Çimen, İ., Savaş, B., & Banerjee, S. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08677.x · Cited by 41
Awasthee, N., Rai, V., Verma, S. S., Francis, K. S., Nair, M. S., & Gupta, S. C. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.08.016 · Cited by 42
Self-citationResearch progress of NF-κB signaling pathway and thrombosis
Wang, Z., Fang, C., Yao, M., Wu, D., Chen, M., Guo, T., & Mo, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1257988 · Cited by 41
Relevance of systems pharmacology in drug discovery
Cucurull-Sanchez, L., Spink, K. G., & Moschos, S. A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.01.015 · Cited by 42
Elkamhawy, A., Hassan, A. H. E., Paik, S., Lee, Y. S., Lee, H., Shin, J., Lee, K., & Roh, E. J. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.01.017 · Cited by 42
Dawood, M., Ooko, E., & Efferth, T. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00542 · Cited by 41
Mohankumar, K., Francis, A. P., Pajaniradje, S., & Rajagopalan, R. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06610-8 · Cited by 41
TLR4 and TNFR1 blockade dampen M1 macrophage activation and shifts them towards an M2 phenotype
Sawoo, R., Dey, R., Ghosh, R. B., & Bishayi, B. (2021) · Immunologic Research · doi:10.1007/s12026-021-09209-0 · Cited by 42
Namkoong, S., Kim, T., Jang, I., Kang, K.-W., Oh, W. K., & Park, J. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.203 · Cited by 40
Vrba, J., Orolinová, E., & Jitka Ulrichová, A. (2011) · Fitoterapia · doi:10.1016/j.fitote.2011.11.022 · Cited by 40
Targeting NF-κB p65 with a Helenalin Inspired Bis-electrophile
Widen, J. C., Kempema, A., Villalta, P. W., & Harki, D. A. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00751 · Cited by 40
Targeting Chromatin Remodeling in Inflammation and Fibrosis
Yang, J., Tian, B., & Brasier, A. R. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2016.11.001 · Cited by 40
Anti-Cancer Phytometabolites Targeting Cancer Stem Cells
Torquato, H. F. V., Goettert, M. I., Justo, G. Z., & Paredes‐Gamero, E. J. (2017) · Current Genomics · doi:10.2174/1389202917666160803162309 · Cited by 41
Guesmi, F., Prasad, S., Tyagi, A. K., & Landoulsi, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.115 · Cited by 40
Natural cyclopeptide RA-V inhibits the NF-κB signaling pathway by targeting TAK1
Wang, Z., Zhao, S., Song, L., Pu, Y., Wang, Q., Zeng, G., Liu, X., Bai, M., Li, S., Gao, F., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0743-2 · Cited by 40
Liu, F., Zhang, Y.-Y., Song, N., Lin, J., Liu, M.-K., Huang, C., Zhou, C., Wang, H., Wang, M., & Shen, J. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.04.018 · Cited by 40
A new labdane diterpenoid with anti-inflammatory activity from Thuja orientalis
Kim, T.-H., Li, H., Wu, Q., Lee, H. J., & Ryu, J. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.02.001 · Cited by 40
Microgreens: A Next Generation Nutraceutical for Multiple Disease Management and Health Promotion
Rizvi, A., Sharma, M., & Saxena, S. (2022) · Genetic Resources and Crop Evolution · doi:10.1007/s10722-022-01506-3 · Cited by 39
Mohankumar, K., Sridharan, S., Pajaniradje, S., Singh, V. K., Ronsard, L., Banerjea, A. C., Somasundaram, D. B., Coumar, M. S., Periyasamy, L., & Rajagopalan, R. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.07.024 · Cited by 39
Wu, C., Chen, P., Li, T., Fong, Y., & Tang, C. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-277 · Cited by 39
Tom, S., Rane, A., Katewa, A., Chamoli, M., Matsumoto, R. R., Andersen, J. K., & Chinta, S. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1636-9 · Cited by 39
Anilkumar, N. C., Mohan, C. D., Rangappa, S., Ananda, H., Sukhorukov, A. Y., Shanmugam, M. K., Sundaram, M. S., Nayaka, S. C., Girish, K. S., Chinnathambi, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163209 · Cited by 38
Wang, Q., Zhou, X., Yang, L., Luo, M., Han, L., Lu, Y., Shi, Q. W., Wang, Y., & Liang, Q. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.11.126 · Cited by 38
The Toxic Mechanism of Gliotoxins and Biosynthetic Strategies for Toxicity Prevention
Ye, W., Liu, T., Zhang, W., & Zhang, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413510 · Cited by 38
Lee, S.-T., Wong, P., He, H., Hooper, J. D., & Mustafa, M. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057708 · Cited by 38
Cistanche deserticola extract increases bone formation in osteoblasts
Li, T., Huang, H., Su, C., Ho, T., Wu, C., Chen, W., Fong, Y., & Tang, C. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01483.x · Cited by 40
Zhao, Y., Zhang, D., Wang, S., Li, T., Wang, A., Chen, W., Zhu, Z., Zheng, S., Gao, X., & Lu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056557 · Cited by 37
Lu, S., Wang, C., Jin, Y., Meng, Q., Liu, Q., Liu, Z., Liu, K., Sun, H., & Liu, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-03187-w · Cited by 37
Cellular stress response mechanisms as therapeutic targets of ginsenosides
Qi, H., Li, L., & Ma, H. (2017) · Medicinal Research Reviews · doi:10.1002/med.21450 · Cited by 39
Wang, W., Wu, Y., Yang, K., Wu, C., Tang, R., Li, H., & Chen, L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.04.022 · Cited by 37
Huang, H., Cai, B., Suen, C., Lee, H.-Y., Hwang, M., Liu, F., & Kannagi, R. (2020) · Cells · doi:10.3390/cells9020397 · Cited by 37
Nuclear Factor Kappa B in Autism Spectrum Disorder: A Systematic Review
Liao, X., & Li, Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104918 · Cited by 37
Cho, H., Lee, K. Y., & Park, J. H. Y. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141020564 · Cited by 37
Bai, C.-H., Yang, X., Zou, K., He, H., Wang, J., Qin, H.-L., Yu, X., Liu, C., Zheng, J., Cheng, F., et al. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1217-7 · Cited by 37
Lu, L., Shi, W., Deshmukh, R. R., Long, J., Cheng, X., Ji, W., Zeng, G., Chen, X., Zhang, Y., & Dou, Q. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113783 · Cited by 36
Huang, L., Qin, L., Wen, R., Yu, Z., Li, N., Ma, L., & Feng, W. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.01.021 · Cited by 36
Stelma, T., & Leaner, V. D. (2017) · Oncotarget · doi:10.18632/oncotarget.15834 · Cited by 36
Dong, X., Sun, R., Wang, J., Yu, S.-Z., Cui, J., Guo, Z., Pan, X., Sun, J. T., Yang, J., & Pan, L. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114289 · Cited by 37
Aliabadi, M., Chee, B. S., Matos, M., Cortese, Y. J., Nugent, M., de Lima, T. A. M., Magalhães, W. L. E., & de Lima, G. G. (2020) · Polymers · doi:10.3390/polym12122807 · Cited by 36
Plant derived inhibitors of NF-κB
Golan‐Goldhirsh, A., & Gopas, J. (2013) · Phytochemistry Reviews · doi:10.1007/s11101-013-9293-5 · Cited by 36
Fetoni, A. R., Paciello, F., & Troiani, D. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0183 · Cited by 37
Diversity of NF-κB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease
Manou-Stathopoulou, S., & Lewis, M. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2022.101649 · Cited by 35
Targeting Nrf2 and NF-κB Signaling Pathways in Cancer Prevention: The Role of Apple Phytochemicals
Gado, F., Ferrario, G., Vedova, L. D., Zoanni, B., Altomare, A., Carini, M., Aldini, G., D’Amato, A., & Baron, G. (2023) · Molecules · doi:10.3390/molecules28031356 · Cited by 35
Anti-Müllerian hormone: biology and role in endocrinology and cancers
Gowkielewicz, M., Lipka, A., Zdanowski, W., Waśniewski, T., Majewska, M., & Carlberg, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1468364 · Cited by 38
Diet and proinflammatory cytokine levels in head and neck squamous cell carcinoma
Arthur, A. E., Peterson, K. E., Shen, J., Djurić, Z., Taylor, J. M. G., Hébert, J. R., Duffy, S. A., Peterson, L. A., Bellile, E. L., Whitfield, J. R., et al. (2014) · Cancer · doi:10.1002/cncr.28778 · Cited by 35
Nanotherapeutics for anti-inflammatory delivery
Marzio, L. D., Ventura, C. A., Cosco, D., Paolino, D., Stefano, A. D., Stancanelli, R., Tommasini, S., Cannavà, C., Celia, C., & Fresta, M. (2015) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2015.10.011 · Cited by 35
Resveratrol induces nuclear factor-κB activity in human cardiac cells
Palomer, X., Capdevila-Busquets, E., Álvarez-Guardia, D., Barroso, E., Pallàs, M., Camins, A., Davidson, M. M., Planavila, A., Villarroya, F., & Vázquez‐Carrera, M. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.006 · Cited by 35
Elkamhawy, A., Kim, N. Y., Hassan, A. H. E., Park, J.-E., Paik, S., Yang, J.-E., Oh, K., Lee, B. H., Lee, M. Y., Shin, K. J., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111955 · Cited by 35
Zhou, P., Hua, F., Wang, X., & Huang, J.-L. (2020) · Inflammopharmacology · doi:10.1007/s10787-019-00680-8 · Cited by 35
Shang, H., Guo, J., Wang, P., Li, L., Tian, Y., Li, X., & Zou, Z. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114511 · Cited by 35
Shin, H.-J., Kim, H., Kim, S.-J., Chung, W., Kim, S. S., & Um, J. (2011) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2011.552508 · Cited by 35
Switzer, C., Cheng, R. Y. S., Ridnour, L. A., Murray, M. C., Tazzari, V., Sparatore, A., Soldato, P. D., Hines, H. B., Glynn, S. A., Ambs, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3115 · Cited by 35
Leo, A. D., Arena, G., Stecca, C., Raciti, M., & Mattia, E. D. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0145 · Cited by 35
Rezagholizadeh, L., Pourfarjam, Y., Nowrouzi, A., Nakhjavani, M., Meysamie, A., Ziamajidi, N., & Nowrouzi, P. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0128-6 · Cited by 38
Azelmat, J., Fiorito, S., Taddeo, V. A., Genovese, S., Epifano, F., & Grenier, D. (2015) · Phytochemistry Letters · doi:10.1016/j.phytol.2015.08.008 · Cited by 34
Armstrong, M. J., Stang, M. T., Liu, Y., Yan, J., Pizzoferrato, E., & Yim, J. H. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1046646 · Cited by 34
Metadata
- Authors
- Gupta, S. C., Sundaram, C., Reuter, S., & Aggarwal, B. B.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Aggarwal, Bharat B.
- Venue
- Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 1799
- Issue
- 10-12
- Pages
- 775-787
- ISSN
- 1874-9399 (ISSN-L)
- PMC
- PMC2955987
- OpenAlex
- W1973354681
- Cited by
- 762
- References
- 232
- Citations by year
- 2026: 38 · 2025: 32 · 2024: 39 · 2023: 36 · 2022: 42 · 2021: 59 · 2020: 63 · 2019: 66 · 2018: 70 · 2017: 63 · 2016: 45 · 2015: 45 · 2014: 41 · 2013: 50 · 2012: 35
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA-16672, P01CA091844, P01CA124787, CA-124787-01A2, P30CA016672)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- NF-κB signaling, NF-κB inhibitors, small molecules, canonical NF-κB pathway, non-canonical NF-κB signaling, protein kinases, proteasome inhibitors, protein phosphatase, inflammation, cancer, chronic disease
- MeSH terms
- Animals, Cell Survival, Cell Transformation, Neoplastic, Gene Expression Regulation, Humans, Inflammation, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Phosphorylation, Signal Transduction, NF-kappa B, Neovascularization, Physiologic, Cell Proliferation, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review